Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-285826
Filing Date
2011-10-28
Accepted
2011-10-28 13:58:50
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d239788d10q.htm 10-Q 530580
2 SECTION 302 CEO CERTIFICATION d239788dex311.htm EX-31.1 9211
3 SECTION 302 CFO CERTIFICATION d239788dex312.htm EX-31.2 9392
4 SECTION 906 CEO CERTIFICATION d239788dex321.htm EX-32.1 3618
5 SECTION 906 CFO CERTIFICATION d239788dex322.htm EX-32.2 3796
  Complete submission text file 0001193125-11-285826.txt   2235523

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pard-20110930.xml EX-101.INS 332619
7 XBRL TAXONOMY EXTENSION SCHEMA pard-20110930.xsd EX-101.SCH 12194
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pard-20110930_cal.xml EX-101.CAL 31118
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pard-20110930_lab.xml EX-101.LAB 113746
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pard-20110930_pre.xml EX-101.PRE 73828
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 111164595
SIC: 2834 Pharmaceutical Preparations